Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 19 of the 32 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
Overview
CoChat Summary
TL;DR
This study used post-mortem brain transcriptomics and co-expression network analysis to show that autism spectrum disorder (ASD) cortex has convergent molecular abnormalities, including attenuated frontal-temporal regional expression differences and distinct neuronal and immune-glial co-expression modules. It further links a down-regulated neuronal module to autism genetic association signals and demonstrates A2BP1-dependent differential splicing in ASD brain.
Key findings
- In autism cortex, 444 genes were differentially expressed (DE) versus controls, while only 2 genes were DE in cerebellum; the 209 down-regulated genes were enriched for synaptic function and the 235 up-regulated genes for immune/inflammatory response. In an independent BA44/45 replication cohort, 97 genes were DE and 81 overlapped with the initial cohort (p=1.2E-93), with the same direction of change for all but 2 of the 81.
- Regional cortical patterning was attenuated in ASD: 174 genes were DE between control BA9 and BA41 at FDR<1%, but none were DE in the same regional comparison among ASD cases; relaxing to FDR 5% identified over 500 DE genes in controls and only 8 in ASD brains.
- Weighted gene co-expression network analysis identified an under-expressed neuronal module (M12) enriched for known autism susceptibility genes (p=6.1E-4), including CADPS2, AHI1, CNTNAP2, and SLC25A12, and an up-regulated immune-glial module (M16). M12 showed significant enrichment for autism GWAS association signals (p=5E-4), whereas M16 and the DE gene list did not.
- RNA-Seq on 3 ASD samples with low A2BP1 and 3 controls identified 212 significant alternative splicing events; 36 overlapped with predicted A2BP1/2 targets (p=2.2E-16), and RT-PCR confirmed 85% of tested differential splicing changes involving predicted A2BP1 targets.
Methods
- Post-mortem brain tissue was obtained from the Autism Tissue Project, Harvard Brain Bank, and MRC London Brain Bank. Illumina microarrays profiled superior temporal gyrus (BA41/42), prefrontal cortex (BA9), and cerebellar vermis; after filtering, 58 cortex samples (29 ASD, 29 controls) and 21 cerebellum samples (11 ASD, 10 controls) were analyzed, with an independent BA44/45 replication cohort of 9 ASD cases and 5 controls.
- Analyses included differential expression, supervised hierarchical clustering, weighted gene co-expression network analysis (WGCNA), gene ontology enrichment, and GWAS set enrichment using a published autism GWAS dataset plus negative-control GWAS datasets.
- High-throughput RNA-Seq was performed on 3 ASD samples with significant A2BP1 down-regulation (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels, followed by RT-PCR validation.
Limitations
- The paper does not include a dedicated limitations section.
- The text makes evident that the RNA-Seq comparison used a very small sample (3 ASD, 3 controls) and the replication cohort was also small (9 ASD, 5 controls).
- The study relies on post-mortem brain tissue; potential confounders such as age, sex, RNA integrity number, post-mortem interval, seizure co-morbidity, and medication were assessed, but the authors state that immune changes have no evidence of a common genetic component and are most likely secondary or environmental.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 8 Not checked · 93 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The hubs of M12, i.e. the genes with the highest rank of M12 membership 8 , were A2BP1, APBA2, SCAMP5, CNTNAP1, KLC2, CHRM1 (Supplementary Data).”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation is attached to the definition of module membership used to identify hubs, not to the six-gene list, which the citing sentence attributes to its Supplementary Data. The Results section (“Module membership is highly consistent”; page unavailable) defines module membership, and the Methods section (“Defining a measure of module membership (kME)”; page unavailable) explains how genes are ranked by it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions 8 .”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation supports the sentence’s final clause: the Results sections ‘Conserved modules are enriched for markers of cell classes’ and ‘Relationships between modules are highly preserved’ describe reproducible co-expression modules associated with cell types and biological functions. The similarity of the citing authors’ control network to earlier networks is their own comparison, reported in their Supplementary Table 7, rather than a finding attributed to this source. Page numbers were not available in our copy. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“M12 showed significant overrepresentation of known autism susceptibility genes 2 (Supplementary Table 10; p = 6.1E-4), including CADPS2 , AHI1 , CNTNAP2 , and SLC25A12”
What the sources say
- Partly supportedcites [2] 2. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466:368-372. [PubMed: 20531469] sourceExperimental — accuracy not yet measured
The main text (Figure 2 and the accompanying results; page not provided) discusses a set of ASD-implicated genes, supporting the general description attached to citation 2. Our copy does not identify CADPS2, AHI1, CNTNAP2, or SLC25A12 as members of that set, so it cannot verify the specific examples. The M12 enrichment and p value are presented as the citing paper’s own analysis, not as findings of this source. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The first three of these genes have previously been implicated in autism 14-16”
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Babatz TD, Kumar RA, Sudi J, Dobyns WB, Christian SL. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res. 2009; 2:359-364. [PubMed: 20029827] source
- Supportedcites [15] 15. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010; 19:13681378. [PubMed: 20071347] source
The Abstract identifies SCAMP5 as a candidate gene for autism and reports its disruption in a patient with autism. In the citing sentence’s group of three references, this paper supports the SCAMP5 portion of the claim. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] 16. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B:869-876. [PubMed: 17503474] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“showed significant similarity to two modules identified in previous studies of normal human brain 8 : an astrocyte module and a microglial module.”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The Results section identifies a module of coexpressed genes with characteristics of microglia in human brain. The citation identifies the earlier microglial module; the statement that the citing study’s M16 was significantly similar to it is the citing authors’ comparison, not a finding attributed to Oldham et al. No page number is available in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
95 more claims · 6 with their cited sources checked
Create a free account to see all 117 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although there was no significant DGE in the cerebellum (FDR < 0.05, P distributions in Fig. 1b), similar to observations in a smaller cohort8, there was a replication signal in the cerebellum and overall concordance between ASD-related fold changes in the cortex and cerebellum (Extended Data Fig. 2f–h).”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results are consistent with previous studies in post-mortem brain that identified dysregulation of gene expression in microglia but enriched expression of ASD risk genes only in neuronal cells (Ruzzo et al., 2019; Gandal et al., 2018a, 2018b; Voineagu et al., 2011).”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene expression changes in postmortem brain overlap with developmentally regulated genes involved in cortical patterning as well as in cell cycle, proliferation and neural differentiation6, 7.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis was supported both by the significant overlap between candidate autism-susceptibility genes and Rbfox target genes and by the significant overlap of predicted Rbfox target exons and exons altered in autistic brains with down-regulation of Rbfox1 (Voineagu et al., 2011).”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measured
81 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 5×
“We next applied weighted-gene co-expression network analysis (WGCNA) 8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.”
InfluentialSelf-citationPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“These results indicate that (1) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (2) the upregulation of immune response genes in the autistic brain observed by us and others(25) has no evidence of a common genetic component.”
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Self-citationAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 3×
“%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“In addition, comparison of these DE results with another, smaller study of the STG in ASD 7 , revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).”
Research works printed but not linked: 1
- 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] · DOI · Paper page
Cited by
Items 1,001–1,100 of 1,888
Trudler, D., Ghatak, S., Bula, M., Parker, J., Talantova, M. V., Luevanos, M., Labra, S. R., Grabauskas, T., Noveral, S. M., Teranaka, M., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02761-9 · Cited by 27
“Impor-tantly, recent comprehensive transcriptome analyses of autistic brains identi fi ed MEF2C as one of the frequently dysregulated genes in children with ASD even without MEF2 mutations per se [20, 21, 26, 27].”
Self-citationGriesi‐Oliveira, K., Sunaga, D. Y., Alvizi, L., Vadasz, E., & Passos‐Bueno, M. R. (2013) · Autism Research · doi:10.1002/aur.1296 · Cited by 23
“Transcriptome analysis in ASD has shown deregulation of genes and pathways related to neurological functions and central nervous system development [Baron, Liu, Hicks, & Gregg, 2006; Gregg et al., 2008; Hu, Frank, Heine, Lee, & Quackenbush, 2006; Hu et al., 2009a,b; Seno et al., 2010; Voineagu et al., 2011].”
BackgroundLin, Z., Sanders, S., Li, M., Šestan, N., State, M. W., & Zhao, H. (2015) · The Annals of Applied Statistics · doi:10.1214/14-aoas802 · Cited by 21
Genome-Wide Changes in Protein Translation Efficiency Are Associated with Autism
Rogozin, I. B., Gertz, E. M., Baranov, P. V., Poliakov, E., & Schäffer, A. A. (2018) · Genome Biology and Evolution · doi:10.1093/gbe/evy146 · Cited by 29
“The large variations in incidence and prevalence suggest that local regulations (Rzhetsky et al. 2014) and/or local environmental factors (Volk et al. 2011) are associated with ASD incidence.”
Ding, Q., Sethna, F., Wu, X., Miao, Z., Chen, P., Zhang, Y., Xiao, H., Feng, W., Feng, Y., Li, X., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0833-4 · Cited by 19
Torrico, B., Antón-Galindo, E., Fernàndez‐Castillo, N., Francàs, E. R., Ghorbani, S., Pineda-Cirera, L., Hervas, A., Rueda, I., Moreno, E., Fullerton, J. M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061851 · Cited by 19
Protein Interaction Networks Reveal Novel Autism Risk Genes within GWAS Statistical Noise
Correia, C., Oliveira, G., & Vicente, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112399 · Cited by 22
“Thus far the use of protein networks to address common risk variants in ASD was limited to enrichment analysis of GWAS top hit genes in co-expressed or differentially expressed networks [51,67].”
BackgroundPostmortem human brain genomics in neuropsychiatric disorders — how far can we go?
Jaffe, A. E. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.11.002 · Cited by 19
Alex, A. M., Saradalekshmi, K. R., Shilen, N., Suresh, P. A., & Banerjee, M. (2019) · IUBMB Life · doi:10.1002/iub.2021 · Cited by 23
Qin, Q., Li, M., Fan, L., Zeng, X., Zheng, D., Wang, H., Jiang, Y., Ma, X., Xing, L., Wu, L., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02988-0 · Cited by 26
“Four expression pro fi ling datasets of the postmortem brain tissue in ASD individuals including GSE38322 [28] (ASD = 14, Control = 12), GSE59288 (ASD = 25, Control = 38), GSE64018 [29] (ASD = 12, Control = 12) and GSE30573 [30] (ASD = 3, Control = 3) from the GEO database.”
New treatment targets for autism spectrum disorders: EU-AIMS
Loth, E., Spooren, W. P. J. M., & Murphy, D. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00004-2 · Cited by 22
A survey of RNA editing at single-cell resolution links interneurons to schizophrenia and autism
Ansell, B. R. E., Thomas, S. N., Bonelli, R., Munro, J. E., Freytag, S., & Bahlo, M. (2021) · RNA · doi:10.1261/rna.078804.121 · Cited by 21
“Three individually significant dEd sites were identified in RBFOX1 and RIMS2 respectively, with two sites each in DNAJC11, EPN2, PEAK1, andTPST1 (Supplemental Table S7).”
BackgroundInfluentialWang, W., & Fu, P. (2023) · Microorganisms · doi:10.3390/microorganisms11020291 · Cited by 24
Teng, P., Li, Y., Ku, L., Wang, F., Goldsmith, D. R., Wen, Z., Yao, B., & Feng, Y. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.009 · Cited by 20
“In fact, inflammatory and innate immune genes are enriched in SCZ and ASD affected pathways (Hughes et al., 2023; Khandaker et al., 2015; Voineagu et al., 2011).”
Bordt, E. A., Moya, H., Jo, Y. C., Ravichandran, C. T., Bankowski, I. M., Ceasrine, A. M., McDougle, C. J., Carlezon, W. A., & Bilbo, S. D. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.010 · Cited by 26
Neuroepigenomics: resources, obstacles, and opportunities
Satterlee, J. S., Beckel-Mitchener, A. C., Little, A. R., Procaccini, D. C., Rutter, J. L., & Lossie, A. C. (2015) · Neuroepigenetics · doi:10.1016/j.nepig.2014.10.001 · Cited by 18
Alves, A. C., Bruhn, S., Ramasamy, A., Wang, H., Holloway, J. W., Hartikainen, A., Järvelin, M., Benson, M., Balding, D. J., & Coin, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074821 · Cited by 19
“One way of mapping GWAS pathway results onto the molecular mechanism of disease is to examine the molecular connections with other disease-dysregulated pathways [13–16] and pathway sub-networks [17,18].”
BackgroundRadulescu, E., Ganeshan, B., Minati, L., Beacher, F. D. C. C., Gray, M. A., Chatwin, C. R., Young, R. C. D., Harrison, N. A., & Critchley, H. (2012) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.3 · Cited by 19
The frontier of RNA metamorphosis and ribosome signature in neocortical development
Kraushar, M. L., Popovitchenko, T., Volk, N. L., & Rašin, M. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.02.003 · Cited by 20
“…on Autism Spectrum isorders focusing on abnormalities at the genomic (Bartlett et al., 005; Morrow et al., 2008; Weiss et al., 2009; Pinto et al., 2010; anders et al., 2011; Michaelson et al., 2012; O’Roak et al., 2012) nd transcriptomic (Voineagu et al., 2011; Parikshak et al., 2013) evels.”
BackgroundO ENIGMA DO AUTISMO: CONTRIBUIÇÕES SOBRE A ETIOLOGIA DO TRANSTORNO
Fadda, G. M., & Cury, V. E. (2016) · Psicologia em Estudo · doi:10.4025/psicolestud.v21i3.30709 · Cited by 109
“…Happé (1999) propôs o autismo como um estilo cognitivo; Baron-Cohen (2002) defendeu que os indivíduos Asperger’s não sejam vistos como deficientes; Voineagu et al. (2011) apoiaram o conceito de neurodiversidade com seu estudo da análise do genoma humano; Ekblad (2013) definiu a neurodiversidade…”
BackgroundExpression Analysis of BDNF, BACE1, and Their Natural Occurring Antisenses in Autistic Patients
Ghafouri-Fard, S., Namvar, A., Arsang-Jang, S., Komaki, A., & Taheri, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01432-7 · Cited by 17
Understanding the circuit basis of cognitive functions using mouse models
Nakajima, M., & Schmitt, L. I. (2019) · Neuroscience Research · doi:10.1016/j.neures.2019.12.009 · Cited by 22
Zhu, Y., Mordaunt, C. E., Durbin-Johnson, B. P., Caudill, M. A., Malysheva, O., Miller, J. W., Green, R., James, S. J., Melnyk, S. B., Fallin, M. D., et al. (2020) · Autism Research · doi:10.1002/aur.2428 · Cited by 28
“Previous studies in ASD have been focused on post mortem brain tissue [Ginsberg, Rubin, Falcone, Ting, & Natowicz, 2012; Voineagu et al., 2011], as a tissue relevant to the condition, but collected after diagnoses were made, raising concerns about reverse causation in determining…”
BackgroundMizuno, S., Hirota, J.-N., Ishii, C., Iwasaki, H., Sano, Y., & Furuichi, T. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.595607 · Cited by 19
“Networkbased analysis of large-scale transcriptome data also highlights that co-expression modules related to synaptic development, neuronal activity, and immune function are deregulated in ASD (Voineagu et al., 2011; Gupta et al., 2014; de la Torre-Ubieta et al., 2016).”
BackgroundHuman iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development
Heider, J., Vogel, S., Volkmer, H., & Breitmeyer, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910254 · Cited by 26
“Transcriptome analysis revealed a deregulation of genes involved in synaptic function as well as an upregulation of microglial genes as further evidence for a general inflammatory state in ASD [72,73].”
BackgroundLeveraging a translational research approach to drive diagnostic and treatment advances for autism
Parker, K. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01532-8 · Cited by 23
“Therefore, it seems more likely that brain AVP signaling is impacted by the convergence of multiple ASD susceptibility variants [64, 72].”
BackgroundSartor, F., Anderson, J., McCaig, C., Miedzybrodzka, Z., & Müller, B. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150168 · Cited by 23
The use of stem cells to study autism spectrum disorder.
Ardhanareeswaran, K., Coppola, G., & Vaccarino, F. M. (2015) · PubMed Central · Cited by 22
Xie, Z., Li, J., Baker, J. S., Eagleson, K. L., Coba, M. P., & Levitt, P. R. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.022 · Cited by 21
“However, the present proteomics data, together with functional neuroimaging (42) and postmortem human brain studies (13,29,30) and behavioral (43,44), electrophysiology, and morphological analyses of synapse development (20,38–40) in mutant mice, suggest that the MET interactome contributes to NDD expression.”
Salvatore, J. E., Han, S., Farris, S. P., Mignogna, K. M., Miles, M. F., & Agrawal, A. (2018) · Addiction Biology · doi:10.1111/adb.12591 · Cited by 18
“Gene network-based analysis of the transcriptome from adult postmortem brain regions has determined discrete networks associated with CNS disease (including alcohol abuse and dependence), delineating gene sets with convergent GWAS signals (Voineagu et al. 2011; Farris et al. 2015a).”
BackgroundRaciti, M., Salma, J., Spulber, S. D., Gaudenzi, G., Khalajzeyqami, Z., Conti, M., Anderlid, B., Falk, A., Hermanson, O., & Ceccatelli, S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00593 · Cited by 17
Sznajder, Ł. J., Khan, M., Ciesiołka, A., Tadross, M., Nutter, C. A., Taylor, K., Pearson, C. E., Lewis, M. H., Hines, R. M., Swanson, M. S., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01943-0 · Cited by 23
“4a,b), which are regions known to be involved in ASD 58,59 .”
Genetics: Searching for answers
Williams, S. C. P. (2012) · Nature · doi:10.1038/491s4a · Cited by 21
Cellular reprogramming: a novel tool for investigating autism spectrum disorders
Kim, K., Jung, Y. W., Sullivan, G. J., Chung, L., & Park, I. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.002 · Cited by 18
The Metallome as a Link Between the “Omes” in Autism Spectrum Disorders
Stanton, J. E., Malijauskaite, S., McGourty, K., & Grabrucker, A. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.695873 · Cited by 17
“In addition, pathways involved in redox mechanisms and inflammatory processes were in the focus (Voineagu et al., 2011; Feng et al., 2017; Gandal et al., 2018; Schwede et al., 2018; Abraham et al., 2019a; Gordon et al., 2021; Hewitson et al., 2021).”
BackgroundRujeedawa, T., & Zaman, S. H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031315 · Cited by 29
“Despite this rarity, common pathways seem to be involved in autism [123].”
BackgroundLin, C.-W., Septyaningtrias, D. E., Chao, H., Konda, M., Atarashi, K., Takeshita, K., Tamada, K., Nomura, J., Sasagawa, Y., Tanaka, K. Y., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01566-y · Cited by 17
“Studies of monogenic mouse models of autism have contributed to the rapidly accumulating list of ASD-risk genes [3].”
BackgroundInfluentialAutism Spectrum Disorder Genes: Disease-Related Networks and Compensatory Strategies
Lim, H. K., Yoon, J. H., & Song, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.922840 · Cited by 20
“Although the contribution of each gene to the development of ASD is small (less than 1%), it is determined that each gene is part of a distinct biochemical pathway and is engaged in the production of a common output (Voineagu et al., 2011).”
BackgroundMahony, C., & O’Ryan, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.985713 · Cited by 24
Pretzsch, C. M., & Ecker, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1172779 · Cited by 20
“Moreover, regional differences in cortical thickness were enriched for genes (both common and rare variants) previously associated with autism, including those involved in cell differentiation, synaptic functioning, transmembrane receptor activity, synaptic transmission, cell adhesion signaling, and nuclear functionin…”
BackgroundMukund, K., & Subramaniam, S. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1141-9 · Cited by 21
“Modules identified using WGCNA have been repeatedly shown to be biological relevant to the condition under study [4,9].”
Age-related decreased inhibitory vs. excitatory gene expression in the adult autistic brain
van de Lagemaat, L. N., Nijhof, B., Bosch, D. G. M., Kohansal-Nodehi, M., Keerthikumar, S., & Heimel, J. A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00394 · Cited by 17
“We computed these measures for the samples from two publicly available ASD and control microarray datasets derived from cortical brain tissue (Voineagu et al., 2011; Chow et al., 2012).”
BackgroundMethodInfluentialThe genetics and neurobiology of ESSENCE: The third Birgit Olsson lecture
Bourgeron, T. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1042519 · Cited by 21
New Assessments and Treatments in ASD
Choueiri, R., & Zimmerman, A. W. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0443-8 · Cited by 24
Zhang, D., Zhou, C.-K., Chen, S.-Z., Yang, Y., & Shi, B. (2017) · Oncology Letters · doi:10.3892/ol.2017.6267 · Cited by 18
“Co-expression Co-expression networks are generally used to study disease mechanisms (13) and provide a systems level view of dysregulated signaling pathways (14).”
Kamitakahara, A. K., Wu, H., & Levitt, P. R. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24294 · Cited by 16
“The promoter variant reduces MET expression by 30– 50%, measured in human immune cells (Heuer et al., 2011) and neocortex (Campbell et al., 2007; Voineagu et al., 2011).”
BackgroundLee, T. T., Skafidas, E. S., Dottori, M., Zantomio, D., Pantelis, C., Everall, I., & Chana, G. (2017) · Molecular Autism · doi:10.1186/s13229-017-0181-5 · Cited by 18
Lin, C., Chang, K., Lin, C.-Y., Wu, J.-Y., Coon, H. H., Huang, P., Ho, H., Akbarian, S., Gau, S. S., & Huang, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-22753-4 · Cited by 18
Sardaar, S., Qi, B., Dionne‐Laporte, A., Rouleau, G. A., Rabbany, R., & Trakadis, Y. J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02503-5 · Cited by 19
Guan, J., Wang, Y., Lin, Y., Yin, Q., Zhuang, Y., & Ji, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.628539 · Cited by 17
“As ASD is believed to result from functional aberrations within brains, bulk transcriptomic analyses between autistic and normal brains have been applied for identifying aberrant gene expression patterns in ASD (Voineagu et al., 2011; Gupta et al., 2014; Guan et al., 2016; Parikshak et al., 2016).”
BackgroundBristy, S. A., Islam, A., Andalib, K. M. S., Khan, U., Awal, M. A., & Rahman, M. H. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100871 · Cited by 17
Autism Spectrum Disorders in Iran
Mohammadi, M., Salmanian, M., & Akhondzadeh, S. (2011) · InTech eBooks · doi:10.5772/38965 · Cited by 11
“central coherence, brain structure anomalies, cytogenetic abnormalities, and single-gene defects, toxic exposures, teratogens, measles-mumps-rubella vaccines, some prenatal, obstetric and neonatal factors and etc have been specified as the contributing factors in the etiologies of ASDs in the different researches acro…”
BackgroundThe need for a comprehensive molecular characterization of autism spectrum disorders
Broek, J. A. C., Brombacher, E., Stelzhammer, V., Guest, P. C., Rahmoune, H., & Bahn, S. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300117x · Cited by 19
“, 2008) (Voineagu et al., 2011), showed a significant overlap between the brain development genes Abelson helper integration site 1 (AHI1) and Distall-less homeobox 1 (DLX1), which were both down-regulated, and the interferon response genes interferon induced transmembrane protein 2 and 3 (IFITM2 and IFITM3), which we…”
BackgroundBearoff, F. M., del Río, R., Case, L. K., Dragon, J. A., Nguyen-Vu, T., Lin, C.-Y., Blankenhorn, E. P., Teuscher, C., & Krementsov, D. N. (2016) · Genes and Immunity · doi:10.1038/gene.2016.37 · Cited by 17
Ji, C., Tang, Y., Zhang, Y., Huang, X., Li, C., Yang, Y., Wu, Q., Xia, X., Cai, Q., Qi, X.-R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112712 · Cited by 16
Genetic advances in neurodevelopmental disorders
Gao, S., Shan, C., Zhang, R., & Wang, T. (2024) · Medical Review · doi:10.1515/mr-2024-0040 · Cited by 31
Microglial involvement in autism spectrum disorder: insights from human data and iPSC models
Michels, S., Mali, A. S., Jäntti, H., Rezaie, M., & Malm, T. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106071 · Cited by 16
“…repeatedly demonstrated that ASD pathology converges on downregulated synaptic signaling and upregulated immune response and reactive microglia genes (19 ASD cases, Voineagu et al., 2011; 32 ASD cases, Gupta et al., 2014; 48 ASD cases, Parikshak et al., 2016; 49 ASD cases, Gandal et al., 2022).”
Śledziowska, M., Galloway, J., & Baudouin, S. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.011 · Cited by 18
Construction of a Pearson- and MIC-Based Co-expression Network to Identify Potential Cancer Genes
Cao, D., Xu, N., Chen, Y., Zhang, H., Li, Y., & Yuan, Z. (2021) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-021-00485-w · Cited by 21
Yin, X.-R., Wang, X., Wang, S., Xia, Y., Chen, H., Yin, L., & Hu, K. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s354359 · Cited by 18
Self-citationLuan, Y., Cosín‐Tomás, M., Leclerc, D., Malysheva, O., Caudill, M. A., & Rozen, R. R. (2022) · Nutrients · doi:10.3390/nu14051051 · Cited by 16
“Chrm1, which was decreased in FASD female pups, is altered in the cortex of ASD [50] and schizophrenia patients [51].”
BackgroundUnnisa, A., Greig, N. H., & Kamal, M. A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221221142743 · Cited by 18
“Autism has been linked to discontinuous modules of co-expressed genes M16, enriched for astrocyte markers and markers of activated microglia [43].”
Evolutionary and biomedical implications of sex differences in the primate brain transcriptome
DeCasien, A. R., Chiou, K. L., Testard, C., Mercer, A., Valle, J. E. N.-D., Bauman, S. E., González, O., Stock, M. K., Ruiz-Lambides, A. V., Martínez, M. I., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100589 · Cited by 20
Gene expression profiling of the brain: Pondering facts and fiction
Mitchell, A., & Mirnics, K. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.001 · Cited by 18
Zhu, D., Deng, N., & Bai, C. (2015) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2015.2388593 · Cited by 19
Li, D., Tekin, M., Buch, M., & Fan, Y. (2012) · Molecular Cytogenetics · doi:10.1186/1755-8166-5-18 · Cited by 16
“Copy number variations of CHRNA7 and RBFOX1 have been reported in patients with mental retardation, autism and schizophrenia or seizure [16-18].”
BackgroundBlencowe, B. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o2012-019 · Cited by 18
Self-citationFaulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders
Pagliarini, V., Rosa, P. L., & Sette, C. (2017) · Human Genetics · doi:10.1007/s00439-017-1802-y · Cited by 17
Kozol, R. A. (2018) · Journal of Developmental Biology · doi:10.3390/jdb6040029 · Cited by 20
“These biologically relevant networks are constructed by analyzing gene expression profiles, including gene ontology terms and protein-protein interactions [31,66,67].”
BackgroundBaiHui: cross-species brain-specific network built with hundreds of hand-curated datasets
Li, H., Bai, T., Sandford, E., Burmeister, M., & Guan, Y. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty1001 · Cited by 15
Unveiling the Pathogenesis of Psychiatric Disorders Using Network Models
Zuo, Y., Don, W., Zhu, C., Naveed, O., Hong, W., & Yang, X. (2021) · Genes · doi:10.3390/genes12071101 · Cited by 17
Mahony, C., & O’Ryan, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910757 · Cited by 20
“A role for inflammation, astrocyte function and microglial activation is well-supported by transcriptomic and proteomic studies in ASD brain tissue [134-136].”
BackgroundBennett, M. R., & Lagopoulos, J. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.02.007 · Cited by 18
Talebizadeh, Z., Aldenderfer, R., & Chen, X. W. (2013) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3283635526 · Cited by 16
“, 2006a) and recent transcriptomic analysis of autistic brain (Voineagu et al., 2011), the current study provides further evidence that changes at the alternative splicing level should be considered in the etiology of autism.”
BackgroundMethodResultInfluentialTordjman, S., Cohen, D., Coulon, N., Anderson, G. M., Botbol, M., Canitano, R., & Roubertoux, P. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.030 · Cited by 22
Leckman, J. F., & Vaccarino, F. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.052 · Cited by 16
Jeong, J., Yoo, H. J., An, J., & Jeong-Yu, S. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100237 · Cited by 18
Schizophrenia at a Genetics Crossroads: Where to Now?
Corvin, A. P. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt041 · Cited by 17
What does immunology have to do with brain development and neuropsychiatric disorders?
Leckman, J. F., de Alvarenga, P. G., Salto, A. B. R., & Johnson, I. N. S. (2019) · Revista de Medicina · doi:10.11606/issn.1679-9836.v98i4p241-253 · Cited by 23
Agonal Factors Distort Gene-Expression Patterns in Human Postmortem Brains
Dai, J., Chen, Y., Dai, R., Jiang, Y. W., Tian, J., Liu, S., Xu, M. M., Li, M., Zhou, J., Liu, C., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.614142 · Cited by 15
Peripheral Auditory Nerve Impairment in a Mouse Model of Syndromic Autism
McChesney, N., Barth, J. L., Rumschlag, J. A., Tan, J., Harrington, A. J., Noble, K. V., McClaskey, C. M., Elvis, P. R., Vaena, S. G., Romeo, M. J., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0253-22.2022 · Cited by 19
Verrall, C. E., Patel, S., Travitz, L., Tchieu, J. H., Dale, R. C., Kasparian, N. A., Winlaw, D. S., & Blue, G. M. (2023) · Translational Pediatrics · doi:10.21037/tp-22-687 · Cited by 17
“Increasing evidence suggests that inflammation, cellular stress, and epigenetic factors at the gene-environment interface play a key role in the pathogenesis of NDDs (118-120).”
BackgroundInfluentialDuarte‐Campos, J. F., Vázquez‐Moreno, C. N., Martínez‐Marcial, M., Chavarría, A., Carreto, R. J. R., Velasco-Velázquez, M. A., Fuente, M. D. L., & González‐Arenas, A. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16204 · Cited by 20
“Transcriptomic analysis in postmortem samples of individuals with ASD identified the overexpression of immune-related genes and glial markers, particularly those specific to microglia, in the prefrontal, frontal and temporal brain cortices (Velmeshev et al., 2019; Voineagu et al., 2011).”
BackgroundFerrucci, L., Cantando, I., Cordella, F., Angelantonio, S. D., Ragozzino, D., & Bezzi, P. (2023) · Cells · doi:10.3390/cells12242827 · Cited by 19
“For instance, RNA sequencing has revealed a close association between ASD and SZ, with genes linked to glial cell activation, immunity, and inflammation [114–116], as well as an enrichment in microglia and pruning-related modules in ASD patients [115].”
BackgroundTranslating Neurogenomics Into New Medicines
Wendland, J. R., & Ehlers, M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.027 · Cited by 17
Kast, R. J., Wu, H., & Levitt, P. R. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx318 · Cited by 16
Jia, P., Manuel, A. M., Fernandes, B. S., Dai, Y., & Zhao, Z. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab214 · Cited by 16
Beyond Genes: Germline Disruption in the Etiology of Autism Spectrum Disorders
Escher, J., Yan, W., Rissman, E. F., Wang, H. V., Hernández, A., & Corces, V. G. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05304-1 · Cited by 25
Leung, C. S., Rosenzweig, S. J., Yoon, B., Marinelli, N. A., Hollingsworth, E. W., Maguire, A. M., Cowen, M. H., Schmidt, M., Imitola, J., Uzun, E. D. G., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad002 · Cited by 18
Gene coexpression networks reveal key drivers of phenotypic divergence in porcine muscle
Zhao, X. L., Liu, Z., & Liu, Q. (2015) · BMC Genomics · doi:10.1186/s12864-015-1238-5 · Cited by 20
“Because the “hub genes” have the highest degree of within-module connectivity, they were expected to play critical roles in the coexpression network modules and were therefore considered to be a primary indicator of the module function [14,16-21].”
BackgroundMethodInfluentialDecoding dendritic cell function through module and network analysis
Pandey, G. S., Cohain, A. T., Miller, J. C., & Mérad, M. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.09.012 · Cited by 17
Genetic Causes of Autism Spectrum Disorders
Huguet, G., & Bourgeron, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00002-9 · Cited by 20
Zhang, L., Liu, L., Wen, Y. F., Ma, M., Cheng, S., Yang, J., Li, P., Cheng, B., Du, Y., Liang, X., et al. (2018) · Autism Research · doi:10.1002/aur.2001 · Cited by 18
“showed that the mRNAs were regulated by RBFOX1 and significantly enriched for genes involved in cortical development and autism [Voineagu et al., 2011; Parikshak et al., 2013].”
BackgroundStatistical Methods in Genome-Wide Association Studies
Sun, N., & Zhao, H. (2020) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-030320-041026 · Cited by 17
Sadakata, T., Shinoda, Y., Sato, A., Iguchi, H., Ishii, C., Matsuo, M., Yamaga, R., & Furuichi, T. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10126335 · Cited by 16
“The involvement of heredity factors in ASD is strongly suggested by high concordance rates in monozygotic (70%–90%) and dizygotic (0%–10%) twins, and a high risk rate for developing ASD among siblings of a proband (25 times higher than normal) [13].”
BackgroundSolving for X: Evidence for sex‐specific autism biomarkers across multiple transcriptomic studies
Lee, S. C., Quinn, T. P., Lai, J., Kong, S. W., Hertz‐Picciotto, I., Glatt, S. J., Crowley, T. M., Venkatesh, S., & Nguyen, T. (2019) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32701 · Cited by 14
“Rather, these studies have tended to produce inconsistent results, suggesting wide heterogeneity among both the individual patients and the study populations, although several studies have converged to find associations among neuron-specific genes (Gupta et al., 2014; Parikshak et al., 2016; Voineagu et al., 2011).”
ResultIdentification of Homogeneous Subgroups from Resting-State fMRI Data
Yang, H., Vu, T., Long, Q., Calhoun, V. D., & Adalı, T. (2023) · Sensors · doi:10.3390/s23063264 · Cited by 17
“This becomes more challenging for patients with psychiatric disorders because the etiology of a majority of neuropsychiatric illnesses is unclear [3–6], even though studies show that numerous subtypes exist within broad neuropsychiatric disorder domains including schizophrenia [7], bipolar disorder [8], major depressi…”
BackgroundDavoudi, S., Rahdar, M., Hosseinmardi, N., Behzadi, G., & Janahmadi, M. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114286 · Cited by 17
Zhao, S., Zhong, Y., Shen, F., Cheng, X., Qing, X., & Liu, J. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9552 · Cited by 19
“The expression levels of hsa-miR-521, hsa-miR-501-5p, hsa-miR-222-5p, hsa-miR-2681-5p, and hsa-miR-6838-3p in GSE89596, and those of hsa-miR-222-5p, hsa-miR-663b, hsa-miR-514b-5p, hsa-miR-4688, hsa-miR-4743-5p in GSE67979, exhibited the same trend as RNA sequencing results (Figure S4).”
ResultNeuroimmune mechanisms in autism etiology - untangling a complex problem using human cellular models
Vacharasin, J. M., Ward, J. A., McCord, M. M., Cox, K., Imitola, J., & Lizarraga, S. B. (2024) · Oxford Open Neuroscience · doi:10.1093/oons/kvae003 · Cited by 17
“Genome-wide transcriptional profiling of postmortem ASD brains and genome wide association studies (GWAS) identified an overrepresentation of genes involved in immune function in ASD [63].”
Metadata
- Authors
- Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H.
- Affiliations
- University of California, Los Angeles (US)
- University of Toronto (CA)
- King's College London (GB)
- Corresponding author
- Geschwind, Daniel H.
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7351
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3607626
- OpenAlex
- W1995647101
- Cited by
- 1,874
- References
- 38
- Citations by year
- 2026: 91 · 2025: 93 · 2024: 95 · 2023: 111 · 2022: 112 · 2021: 141 · 2020: 131 · 2019: 142 · 2018: 132 · 2017: 127 · 2016: 143 · 2015: 136 · 2014: 137 · 2013: 124 · 2012: 120
- FWCI
- 67.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Autism Speaks
- Genome Canada
- Ontario Genomics Institute
- National Institutes of Health (5r01mh094714-04)
- Canadian Institutes of Health Research
- Medical Research Council
- National Institute of Mental Health (R01-MH094714, R01MH081754, R37MH060233)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, transcriptome, gene co-expression network, splicing dysregulation, A2BP1, alternative exons, autism susceptibility genes, neuronal dysfunction, genetic heterogeneity
- MeSH terms
- RNA Splicing Factors, Autistic Disorder, Brain, Exons, Frontal Lobe, Gene Expression Regulation, Humans, Temporal Lobe, Transcription, Genetic, Case-Control Studies, RNA-Binding Proteins, Alternative Splicing, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.